Evidence map›Paper›PMID 32354900›Full record

ArticleIn vivo (Athens, Greece)

Significant Association of Interleukin-16 Genetic Variations to Taiwanese Lung Cancer.

Meng-Feng Wu, Yun-Chi Wang, Te-Chun Shen, Wen-Shin Chang, Hsin-Ting Li, Cheng-Hsi Liao, Chi-Li Gong, Zhi-Hong Wang, Chia-Wen Tsai, Te-Chun Hsia and 1 more

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Association of functionalOncotarget · 2020
    Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Meng-Feng Wu *Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Yun-Chi Wang *Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Te-Chun Shen *Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Wen-Shin ChangGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Hsin-Ting LiTerry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Cheng-Hsi LiaoGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Chi-Li GongTerry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Zhi-Hong WangDepartment of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
Chia-Wen TsaiGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C. datian@mail.cmuh.org.tw artbau2@gmail.com.
Te-Chun HsiaTerry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C. datian@mail.cmuh.org.tw artbau2@gmail.com.
DA-Tian BauGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C. datian@mail.cmuh.org.tw artbau2@gmail.com.
China Medical University · TWAsia University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimInterleukin-16 has been reported to exhibit tumoricidal effects, however, the contribution of IL-16 genotypes to lung cancer is still largely unrevealed. This study aimed at investigating whether IL-16 genotypes contribute to lung cancer susceptibility. MATERIALS AND

methodsIL-16 rs4778889, rs11556218, and rs4072111 genotypic characteristics were determined among 358 lung cancer patients and 716 controls via the polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) methodology.

resultsThe highlight finding is that the distributions of genotypic (p=8.6E-10) and allelic (p=0.0001) frequencies of IL-16 rs11556218 was significantly different between cases and controls. In detail, the frequencies of IL-16 rs11556218 heterozygous variant TG and homozygous variant GG were 36.6 and 7.3% among the lung cancer patients, significantly higher than those among the controls (22.5% and 2.6%). On the other way, no difference was observed regarding IL-16 rs4778889 or IL-16 rs4072111.

conclusionThe present study indicates IL-16 rs11556218 G allele is significantly associated with increased Taiwan lung cancer risk.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationAgedAllelesAsian PeopleCase-Control StudiesFemaleGenotypeHumansInterleukin-16Lung NeoplasmsMaleMiddle AgedOdds RatioPolymorphism, Single NucleotidePopulation SurveillanceInterleukin-16Genotypeinterleukin-16lung cancersingle nucleotide polymorphism

Identifiers

PMID32354900
PMCPMC7279827
OpenAlexW3022747901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.